# Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds

> **NCT06134843** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Hobart W. Harris** · enrollment: 12 (estimated)

## Conditions studied

- Skin Graft Complications

## Interventions

- **COMBINATION_PRODUCT:** DERMASEAL

## Key facts

- **NCT ID:** NCT06134843
- **Lead sponsor:** Hobart W. Harris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-04-15
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06134843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06134843, "Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06134843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*